# DESCRIPTION

## BACKGROUND OF THE INVENTION

- introduce field of invention
- describe mesenchymal stem cells
- motivate targeted therapy of metastatic cancer
- describe TRAIL and its properties
- describe HSV-TK and its properties
- limitations of TRAIL therapy
- limitations of HSV-TK therapy
- motivate combination of TRAIL and HSV-TK
- describe prior art of dodecameric TRAIL
- describe suicide gene therapy
- describe bystander effect
- describe HSV-TK and ganciclovir
- motivate invention of vector coexpressing TRAIL and HSV-TK

## SUMMARY OF THE INVENTION

- summarize objects of the invention

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

- define dodecameric TRAIL
- describe structure of dodecameric TRAIL
- introduce secretion signal sequence
- describe function of secretion signal sequence
- introduce dodecamer-forming domain
- describe function of dodecamer-forming domain
- describe composition of DNA cassette
- introduce suicide gene
- describe function of suicide gene
- introduce HSV-TK as suicide gene
- describe codon optimization
- introduce IRES sequence
- describe function of IRES sequence
- describe preparation of dTRAIL-IRES-TK cassette
- introduce recombinant expression vector
- describe essential regulatory elements
- introduce adenoviral vector
- describe advantages of adenoviral vector
- introduce recombinant adenovirus
- describe preparation of recombinant adenovirus
- introduce host cell
- describe coexpression of dodecameric TRAIL and HSV-TK
- introduce stem cell
- describe advantages of stem cell
- introduce human MSC
- describe tumor-tropic property of MSC
- describe preparation of MSC/dTRAIL-TK
- introduce composition for treating cancer
- describe active ingredients
- introduce pharmaceutically acceptable carrier
- describe dosage forms
- introduce administration routes
- describe administration modes
- introduce therapeutic effects
- describe cancer types
- introduce metastatic carcinoma mouse model
- describe evaluation of cancer therapeutic effects
- introduce method for treating cancer
- describe administration of composition
- describe administration of GCV

### Example 1

- construct tPA-SPD-TRAIL DNA cassette
- describe preparation of pShuttle-Tet10/tPA-SPD-TRAIL vector

### Example 2

- construct dTRAIL-IRES-TK cassette
- describe preparation of pAd/dTRAIL-IRES-TK vector

### Example 3

- examine TRAIL and HSV-TK expressions by MSC/dTRAIL-TK

### Example 4

- examine effect of GCV treatment on cell survival rate and TRAIL expression level of MSC/dTRAIL-TK

### Example 5

- co-culture experiment design
- analyze tumor cell death results

### Example 6

- metastatic cancer mouse model design
- evaluate therapeutic efficacy results

### Example 7

- repeated administration experiment design
- analyze complete remission rate results

## EFFECT OF THE INVENTION

- summarize advantages

